Suchergebnisse - "Curigliano, G"

PubPharm (286)

61

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

enthalten in: ESMO open | 2021

von Gyawali, B. | de Vries, E. | Dafni, U. | +20

62

Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis

enthalten in: Cancer treatment reviews | 2021

von Trapani, D. | Gandini, S. | Corti, C. | +6

63

The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer : The ONCOLLEGE-001 survey

enthalten in: Journal of cancer policy | 2021

von Trapani, D. | Lengyel, C. | Habeeb, B. | +8

64

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

65

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

66

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

67

Commentary : SARS-CoV-2 vaccines and cancer patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Corti, C. | Curigliano, G.

68

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Belli, C. | Penault-Llorca, F. | Ladanyi, M. | +13

69

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

enthalten in: Annals of oncology | 14 January 2021

von Belli, C. | Penault-Llorca, F. | Ladanyi, M. | +13

70

Clinical development and current role of margetuximab for the treatment of breast cancer

enthalten in: Drugs of today | 2021

von Tarantino, P. | Uliano, J. | Morganti, S. | +3